Mature and complete nanobody humanization tec™↓hnology platform, antibody immunogenicity deteλ☆¥ction technology platform, and high-through®"₹↔put nanobody screening technology platf₹¶orm.

Nanjing RegeneCore Biotech Co.,Ltd
Nanjing RegeneCore Biotech♦∑ Co.,Ltd is established in the Biomedi¶δλcal Valley of National Nanjing Jiangbe↓↑i New Area, with a research and office base o₹₹f nearly 4000 square meters. It i♠>s one of the first research and deve£>÷αlopment institutions in the field of nanobodiesλ©δ in China. The compa♠λ§ny's international scientific ∏" consulting expert team has rich experienc≤±™γe in the research and development of cell theraε↔•py products and clinical applications, p ∏roviding strong guaranteeΩ'σs for the precise positioning₹× and success rate of resear ®•ch and development products. The compan≈÷↑y has mature and leading nanε♥Ωobody screening technology, an←<✘↑d conducts in-depth development in mu¶≠×ltiple application fields based on ★ this technology.

NEWS
Nanjing Rongjiekang RC14÷∏<β16 dual antibody has obta∞ ined 2 clinical trial ♥πlicenses again
融捷集團:競逐新賽道(dào),勇攀生(shēng)命科(kē)技£ ₩←(jì)高(gāo)峰
Recruitment of Patients with Moderate to Severe<≈ Asthma
Platforms
High throughput nanobody screening technol ¶$βogy platform, nanobody humanization technol•αogy platform, antiboα≤"dy immunogenicity detection technology plaε↕σtform, biomacromolecule analysis technology γ<÷✔platform, antibody drug CMC process de"£velopment technology platform
TEL:
Address: Room 07 Building 16 Treeh"βδ&ouse, No. 73, Tanmi Road, Ji$ ¥✔angbei New District, Nanjing
Enterprise email:rjk@regenecore.com

WeChat cooperative consultation
You are the th visitor